omniture
Suqiao Biology (Suzhou) Co. LTD

Latest News

CMAB Biopharma and Laekna Therapeutics Enter Strategic Agreement for LAE005 Global Development and Commercialization Partnership

SUZHOU, China, Sept. 10, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), and Laekna The...

2020-09-10 20:08 1032

CMAB Appoints Ms. Maggie Chen as Chief Financial Officer

SUZHOU, China, Aug. 6, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biol...

2020-08-07 08:00 3041

CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months

* CMAB completed a full scope development and manufacturing project for Q-1802 in 9 months for du...

2020-05-13 18:29 1495

CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality

SUZHOU, China, April 3, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated bio...

2020-04-03 09:12 2185

CMAB Biopharma Resumes Full-Scale Operation Following the Coronavirus Disease 2019 (COVID-19) Outbreak

SUZHOU, China, March 23, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), has continued ...

2020-03-23 08:00 1409

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Bio...

2019-12-02 18:28 785

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Bio...

2019-12-02 18:18 545

CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership

* The new partnership will combine the research and development ingenuity of BJ Bioscience with t...

2019-10-11 18:00 2362

CMAB Biopharma Receives Positive Opinion Following External Quality Audit

* CMAB Biopharma today reports a positive opinion from a recent QP audit conducted by Parexel Int...

2019-09-05 18:41 3323

CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody

* This agreement represents the first strategic cooperation between two of the key players in bio...

2019-08-21 21:35 2595

CMAB Biopharma Announces Dr. Wang Yongzhong as CEO to Strengthen Leadership and Continue Business Expansion

SUZHOU, China and NEW YORK, May 20, 2019 /PRNewswire/ -- CMAB Biopharma Limited. (CMAB), a strict "...

2019-05-20 18:30 2258